Ethyl 3-bromo-2-oxocyclohexanecarboxylate, 95%, 5g

2,6-Dichloro-4-methyl-3-nitropyridine, 95.0%, 1g

2-isopropyl-4-pyrimidinecarbaldehyde, 95.0%, 1g

tert-Butyldimethyl(prop-2-ynyloxy)silane, 98%, 500g

2-bromo-N-(2-chlorophenyl)acetamide, 1g

tert-Butyl N-[1-(pyrazin-2-yl)azetidin-3-yl]carbamate, 1g

2,3,4,5-Tetrahydro-1H-benzo[b]azepine, 97.0%, 10g

1,2-Dimethylimidazole, 99.00%, 500g

5-(2-Bromo-4-(trifluoromethyl)phenyl)oxazole, 98%, 250mg

Monitoraggio delle perdite Modello II

(R)-1,1'-Spirobiindane-7,7'-diol>98.0%(GC)1g

4-Methyl-N-(pyridin-2-yl)benzenesulfonamide, 95+%, 1g

3-Imidazol-1-yl-propionic acid, 95.0%, 10g